Effective 01 Jun this year,
Duodart (dutasteride/tamsulosin
hydrochloride) for the treatment
of moderate to severe benign
prostatic hyperplasia (BPH)
became available on the PBS so
that pharmacists can now counsel
potential patients to consult with
their GPs, instead of requiring a
referral to their urologist.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.